Kidney Week

Abstract: PO0779

COVID-19 in CKD: Retrospective, Propensity Score-Matched Cohort Study

Session Information

• COVID-19: CKD and Transplant Patients
  October 22, 2020 | Location: On-Demand
  Abstract Time: 10:00 AM - 12:00 PM

Category: Coronavirus (COVID-19)

• 000 Coronavirus (COVID-19)

Authors

• Dirim, Ahmet Burak, Istanbul Universitesi Istanbul Tip Fakultesi, Istanbul, Turkey

Ahmet Burak Dirim,

• Demir, Erol, Istanbul Universitesi Istanbul Tip Fakultesi, Istanbul, Turkey

Erol Demir,

• Yadigar, Serap, Dr Lufti Kirdar Kartal Egitim ve Arastirma Hastanesi, Istanbul, Turkey

Serap Yadigar,

• Safak, Seda, Istanbul Universitesi Istanbul Tip Fakultesi, Istanbul, Turkey

Seda Safak,

• Parmaks?z, Ergün, Dr Lufti Kirdar Kartal Egitim ve Arastirma Hastanesi, Istanbul, Turkey

Ergün Parmaks?z,

• Guller, Nurana, Istanbul Universitesi Istanbul Tip Fakultesi, Istanbul, Turkey

Nurana Guller,

• Medetalibeyoglu, Alpay, Istanbul Universitesi Istanbul Tip Fakultesi, Istanbul, Turkey

Alpay Medetalibeyoglu,

• Oto, Ozgur Akin, Istanbul Universitesi Istanbul Tip Fakultesi, Istanbul, Turkey

Ozgur Akin Oto,

• Aydin Bahat, Kubra, Dr Lufti Kirdar Kartal Egitim ve Arastirma Hastanesi, Istanbul, Turkey

Kubra Aydin Bahat,

• Oruc, Meric, Dr Lufti Kirdar Kartal Egitim ve Arastirma Hastanesi, Istanbul, Turkey

Meric Oruc,

• Basaran, Seniha, Istanbul Universitesi Istanbul Tip Fakultesi, Istanbul, Turkey

Seniha Basaran,

• Orhun, Günseli, Istanbul Universitesi Istanbul Tip Fakultesi, Istanbul, Turkey

Günseli Orhun,

• Yazici, Halil, Istanbul Universitesi Istanbul Tip Fakultesi, Istanbul, Turkey

Halil Yazici,

• Turkmen, Aydin, Istanbul Universitesi Istanbul Tip Fakultesi, Istanbul, Turkey

Aydin Turkmen,

Background

The prognostic factors for COVID-19 in patients with chronic kidney disease (CKD) are uncertain. We conducted a propensity score-matched study to compare clinical and prognostic features between hospitalized COVID-19 patients with and without CKD.

Methods

Patients with estimated creatinine clearance below 60 ml/min/1.73 m² for more than three months, were included in the CKD group. Fifty-six patients and the propensity score-matched fifty-six control patients were followed-up at least 15 days or until death after diagnosis of COVID-19. All demographic data and diagnostic and therapeutic methods were evaluated. The endpoints were all-cause mortality and acute kidney injury (AKI).

Results

Patient and control groups were reviewed retrospectively over a median follow-up of 44 days (IQR, 36-52 days) after diagnosis of COVID-19. Patients in the CKD group had higher intensive care unit follow-up and mortality rates than the other group, but these results did not reach statistical significance (16 [28.6%] vs. 19 [33.9%]; p=0.54 and 11 [19.6%] vs. 16 [28.6%], p=0.269, respectively). The frequency of AKI was significantly higher in predialysis patients with CKD compared to the other group (8 [14.3%] vs. 5 [45.5%]; p<0.001), but there was no significant difference between the groups in terms of cytokine release syndrome and respiratory failure (13 [23.2%] vs. 8 [14.2%]; p=0.226, 25 [44.6%] vs. 22 [39.3%], p=0.566, respectively). Multivariate logistic regression analysis revealed that respiratory failure (39.283 [95% CI, 7.296 to 211.519; P<0.001] and AKI (10.961 [95% CI, 1.688 to 71.186; P=0.012] were independent risk factors for the mortality.

Conclusion

The prognosis of COVID-19 in patients with CKD is worse than non-uremic patients. Also, AKI and respiratory failure are independent risk factors for mortality.

Table 1. The laboratory results, treatment regimen, and outcomes of the patients

Abbreviations; CKD, chronic kidney disease; CRP, C-reactive protein.